A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis
Clinical trial NCT03585296 · COMPLETED
Trial details
- NCT number
- NCT03585296
- Sponsor
- Aclaris Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-10
- Primary completion
- 2019-04-25
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.